Xolair 50242-0040-62
Generic: Omalizumab
- Manufacturer
- Genentech, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 20, 2003
- Listing Expires
- December 31, 2026
- Application
- BLA103976
Need to source Xolair? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Omalizumab | 150 mg/1.2mL |
Drug Class
Anti-IgE [EPC]Anti-IgE [EPC]Decreased IgE Activity [PE]
Selected Package
50242-0040-62Selected1 VIAL, SINGLE-USE in 1 CARTON (50242-040-62) / 1.2 mL in 1 VIAL, SINGLE-USE
Other packages for this product(1)
1 VIAL, SINGLE-USE in 1 CARTON (50242-040-86) / 1.2 mL in 1 VIAL, SINGLE-USE